Top Headlines

Philips’ iPill showcased at AAPS

Philips’ new intelligent pill (iPill) technology, which combines a sophisticate sensor array with a precise delivery mechanism, was one of the most talked about innovation presented at this year’s AAPS meeting in Atlanta.

BASF certifies excipient range

German chemical giant BASF chose this year’s AAPS meeting in Atlanta, US to showcase its growing library of USP excipient verification certificates, making good on its commitment to apply the highest manufacturing standards to this area of its business.

EMEA view of atypical actives is a ‘pragmatic’ solution

Manufacturers of ingredients used as excipients in pharmaceuticals have faced some regulatory problems with a series substances known as 'atypical actives'.

Authorities seek injunction against Actavis in US

The US authorities are turning up the heat on Icelandic generic drugmaker Actavis over manufacturing problems at the New Jersey plant which makes its recalled Digitek brand of the cardiac drug digoxin.

DSM agrees to Deretil management buyout

DSM Deretil, the chemical side-chain manufacturing operation of DSM's anti-infectives unit, is to go it alone through a management buyout.

News in brief

Today's headlines across the Pharmaceutical industry

Icon secures data management deal with Lilly from OutSourcingPharma

Eli Lilly has continued its march down the outsourcing route and signed a wide-ranging deal with Ireland’s Icon plc in the area of data management.

CVC adds analytical services to its offering from OutSourcingPharma

CiVentiChem president Bhaskar Venepalli says that the CiVentiAnalytical unit, the firm’s new state of the art GLP/cGMP accredited laboratory in Cary, North Carolina, will help customers find novel method development solutions for API production.

etrials sees losses escalate; names new CEO from OutSourcingPharma

eClinical specialist etrials Worldwide saw its losses quadruple in the third quarter on the back of a dip in revenues and financial charges, including a $4m asset impairment charge related to goodwill.

Poland set to remove tax block for clinical trials from OutSourcingPharma

One of the obstacles to the development of Poland’s clinical research market is due to be removed next month, according to local consultancy firm Polish Market Research.

On your radar